NADAC acquisition cost data for APRACLONIDINE HCL 0.5% DROPS. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 17478071610 | $11.32 | 2022-09-21 | Rx |
| 61314066505 | $11.32 | 2022-09-21 | Rx |
| 17478071610 | $11.32 | 2022-09-21 | Rx |
| 61314066505 | $11.32 | 2022-09-21 | Rx |
| 17478071610 | $11.32 | 2022-09-21 | Rx |
| 61314066505 | $11.32 | 2022-09-21 | Rx |
| 17478071610 | $11.32 | 2022-09-21 | Rx |
| 61314066505 | $11.32 | 2022-09-21 | Rx |
| 17478071610 | $11.32 | 2022-09-21 | Rx |
| 61314066505 | $11.32 | 2022-09-21 | Rx |
Generic: Apraclonidine HCl | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $447.4K | 5,306 | 2,038 | $11.36 |
| 2020 | $393.0K | 4,223 | 1,524 | $11.78 |
| 2021 | $389.7K | 4,060 | 1,692 | $11.81 |
| 2022 | $372.6K | 3,962 | 1,695 | $11.72 |
| 2023 | $320.4K | 3,368 | 1,543 | $11.28 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.